<?xml version="1.0" encoding="UTF-8"?>
<ref id="B96-antioxidants-09-01191">
 <label>96.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Chen</surname>
    <given-names>J.-C.</given-names>
   </name>
   <name>
    <surname>Ho</surname>
    <given-names>F.-M.</given-names>
   </name>
   <name>
    <surname>Chao</surname>
    <given-names>P.-D.L.</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>C.-P.</given-names>
   </name>
   <name>
    <surname>Jeng</surname>
    <given-names>K.-C.G.</given-names>
   </name>
   <name>
    <surname>Hsu</surname>
    <given-names>H.-B.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>S.-T.</given-names>
   </name>
   <name>
    <surname>Wu</surname>
    <given-names>W.T.</given-names>
   </name>
   <name>
    <surname>Lin</surname>
    <given-names>W.-W.</given-names>
   </name>
  </person-group>
  <article-title>Inhibition of iNOS gene expression by quercetin is mediated by the inhibition of IÎºB kinase, nuclear factor-kappa B and STAT1, and depends on heme oxygenase-1 induction in mouse BV-2 microglia</article-title>
  <source>Eur. J. Pharm.</source>
  <year>2005</year>
  <volume>521</volume>
  <fpage>9</fpage>
  <lpage>20</lpage>
  <pub-id pub-id-type="doi">10.1016/j.ejphar.2005.08.005</pub-id>
 </element-citation>
</ref>
